| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ee33b0e3e7398cf6fc957eeee59d510
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_40ca166289225aa2dc76e1c5abdac8d3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-77
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57492
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28 |
| filingDate |
2006-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2015-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbd882a59693d148afd85de1b666d0ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a14c40344786faf4c5b80234e0f038f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6452a678faf023a8e9b73db1c42b9f1d |
| publicationDate |
2015-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2538344-T3 |
| titleOfInvention |
Nucleolin as a marker to determine the likelihood of success of cancer treatment with endoestatin |
| abstract |
Method for determining the probability of success of cancer treatment with endestatin in a subject who has a tumor, comprising: a. detecting a tumor sample of said subject for the level of nucleolin expression on the surface of endothelial cells of the blood vessels of said tumor; and b. determining whether said subject is sensitive to endestatin cancer treatment based on the level of nucleolin expression on the surface of endothelial cells, where a higher level of nucleolin expression on the surface of said endothelial cells indicates a greater probability of success of cancer treatment with endostatin. |
| priorityDate |
2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |